MyFinsight
Home
About
Contact
dmac: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, DMAC has $57,047K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
57,047
31,470
Total liabilities and shareholders equity
57,047
31,470
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property, plant and
equipment, gross
$289K
Property and equipment,
net
$150K
Operating lease
right-of-use asset, net
$218K
Deferred offering costs
$456K
Deposits
$200K
Amounts receivable
$260K
Prepaid expenses and
other assets
$445K
Marketable securities
$51,992K
Cash and cash
equivalents
$3,326K
Less accumulated
depreciation
$139K
Total non-current
assets
$824K
Total current assets
$56,223K
Total assets
$57,047K
Total liabilities and
shareholders equity
$57,047K
Total shareholders
equity
$51,622K
Total non-current
liabilities
$157K
Total current
liabilities
$5,268K
Accumulated deficit
-$164,028K
Accumulated other
comprehensive income
$50K
Paid-in capital
$215,600K
Finance lease
obligation
$7K
Operating lease
obligation
$150K
Finance lease
obligation
$10K
Operating lease
obligation
$99K
Accrued liabilities
$3,239K
Accounts payable
$1,920K
Buy me a coffee
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)